The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,788.50
Bid: 1,700.00
Ask: 1,799.00
Change: 0.00 (0.00%)
Spread: 99.00 (5.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks sink on fears over Scottish referendum, Ukraine

Mon, 08th Sep 2014 11:36

Concerns surrounding the upcoming referendum on Scottish independence and a fragile ceasefire agreement in Ukraine were weighing heavily on UK stocks on Monday.London's FTSE 100 was trading down 1% at 6,789 by midday. The index has not closed below the 6,800 mark since 22 August when it settled at 6,775.25.The pound was trading at a 10-month low as the ‘yes’ campaign for Scottish independence gathered steam, with supporters for the break-up taking a narrow lead in a Yougov pool just 10 days before the vote. This was the first lead for the 'yes' lead since the campaign began.Businesses with large Scottish exposure were also rocked by the increased support for independence, with their shares suffering steep falls in morning trading."One could also question how much store we can put in a single poll. For now, the markets are certainly beginning to price in what was deemed unthinkable," said market strategist Brenda Kelly from IG Group.In other news, Ukraine and Russia accused each other of violating the ceasefire that was agreed on Friday, as shelling and gunfire in east Ukraine resumed on Sunday.The city of Mariupol, where a woman was killed on Sunday night, remains in Ukrainian hands but reports say the town on the Sea of Azov could soon come under assault from pro-Russian rebels. Blasts were also heard in Donetsk with both parties reciprocally accusing each other of firing first and threatening the truce.AB Foods and financials in the redFood, ingredients and retail group Associated British Foods fell despite reiterating its guidance for profit growth in the year to 13 September. AB Foods said that strong profit performances from the Primark and grocery divisions and an improvement in ingredients are expected to offset the adverse effect of lower sugar prices and the £50m impact from the recent strength in sterling.Banking and financial stocks were under pressure as investors speculated about how an independent Scotland could affect business. Lloyds, RBS and Standard Life were unwanted, along with utility firm SSE.RBS was also falling heavily after Credit Suisse listed it as one of its "key underperforms" in the European banking sector. HSBC and Standard Chartered were also rated 'underperform'.Glaxosmithkline was trading lower after Credit Suisse slashed its earnings forecasts for the company and trimmed its target price from 1,475p to 1,400p. The bank kept an 'underperform' rating for the stock, saying that it trades at a 10% premium to others in the sector.De La Rue gained after being named preferred bidder for a 10-year contract to print bank notes for the Bank of England from April 2015.Veterinary drugs firm Dechra Pharmaceuticals was also higher after a turnaround in the second half helped full-year revenues to rise 1.6%. The company also said underlying profits jumped 18% as it hiked its dividend by 10%.Market MoverstechMARK 2,828.65 -0.96%FTSE 100 6,788.67 -0.97%FTSE 250 15,702.50 -1.39%FTSE 100 - RisersRandgold Resources Ltd. (RRS) 4,772.00p +0.74%Mondi (MNDI) 1,052.00p +0.67%ARM Holdings (ARM) 960.00p +0.37%Tesco (TSCO) 229.25p +0.33%easyJet (EZJ) 1,370.00p +0.29%Burberry Group (BRBY) 1,496.00p +0.27%Shire Plc (SHP) 5,035.00p +0.20%Glencore (GLEN) 367.25p +0.07%FTSE 100 - FallersAssociated British Foods (ABF) 2,761.00p -5.09%Babcock International Group (BAB) 1,052.00p -4.97%Lloyds Banking Group (LLOY) 71.59p -3.26%Royal Bank of Scotland Group (RBS) 336.00p -3.17%Standard Life (SL.) 403.70p -3.07%Persimmon (PSN) 1,297.00p -2.85%SSE (SSE) 1,472.00p -2.58%Weir Group (WEIR) 2,649.00p -2.57%BAE Systems (BA.) 444.20p -2.54%Ashtead Group (AHT) 1,000.00p -2.34%FTSE 250 - RisersDe La Rue (DLAR) 770.00p +3.63%Supergroup (SGP) 1,223.00p +1.92%Dechra Pharmaceuticals (DPH) 745.00p +1.92%Fidelity China Special Situations (FCSS) 120.50p +1.69%Centamin (DI) (CEY) 66.80p +1.52%Templeton Emerging Markets Inv Trust (TEM) 624.00p +1.22%JPMorgan Emerging Markets Inv Trust (JMG) 605.00p +1.17%Genesis Emerging Markets Fund Ltd Ptg NPV (GSS) 577.00p +1.05%Polar Capital Technology Trust (PCT) 499.50p +1.01%JPMorgan American Inv Trust (JAM) 262.50p +0.88%FTSE 250 - FallersOcado Group (OCDO) 300.50p -5.56%Galliford Try (GFRD) 1,218.00p -4.47%Hochschild Mining (HOC) 162.00p -4.20%Brewin Dolphin Holdings (BRW) 276.30p -4.20%Diploma (DPLM) 654.00p -4.18%Debenhams (DEB) 64.45p -4.09%Ophir Energy (OPHR) 225.30p -3.84%Bellway (BWY) 1,530.00p -3.83%Exova Group (EXO) 180.70p -3.68%Morgan Advanced Materials (MGAM) 305.90p -3.62%
More News
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.